Recruitment and application processes will be coordinated through the IIMS Research Education, Training, and Career Development Program Office:
Jose Cavazos, MD,PhD (email@example.com)
Michael Lichtenstein, MD (firstname.lastname@example.org)
Linda McManus, PhD (email@example.com)
Kathlynn Wray (firstname.lastname@example.org)
UTHSCSA, Room DTL 5.577U
APPLICATION TIMELINE: Applications for upcoming KL2 Scholar positions are due on July 6, 2015. Application reviews and interviews will be completed by early August 2015, and awards will be issued on September 1, 2015 or as funding becomes available.
2015 Informational Meetings: Dr. Cavazos and Dr. McManus will be available to answer your questions.
APPLICATION SUBMISSION: Applications should be submitted by email to KL2 Program Support (see above) as a single PDF document in the order listed under "Application Requirements" below, with the exception of letters of recommendation. Letters of recommendation must be on letterhead, with signature, and may be delivered in hard copy in sealed envelopes or by email from the recommender. Letters of recommendation will not be accepted from the applicant's email. Mentor biosketches, other support form, and trainee tables should be submitted electronically as part of the PDF document.
KL2 PROGRAM APPLICATION TIPS
Top of the Page
Two additional sealed letters of recommendation addressing, at a minimum, the relationship to the applicant (the position on which they base their knowledge of the applicant), and the applicant’s background and potential for a career as an independent research investigator in clinical and/or translational science. At least one of these letters must be from a UT Health Science Center at San Antonio faculty member.
APPLICATION REVIEW AND SELECTION OF KL2 SCHOLARS
KL2 SCHOLAR SELECTION
Links provided from The University of Texas Health Science Center at San Antonio pages to other web sites do not constitute or implyan endorsement of those sites, their content, or products and services associated with those sites.